Seeking Alpha

Shares of AEterna Zentaris (AEZS +13.7%) and Metabolix (MBLX +10.1%) jump after the companies...

Shares of AEterna Zentaris (AEZS +13.7%) and Metabolix (MBLX +10.1%) jump after the companies receive FDA approval for their respective products for bladder cancer treatment (PR) and use in food contact applications (PR).
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs